X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (67) 67
infectious diseases (66) 66
male (59) 59
index medicus (58) 58
female (52) 52
middle aged (50) 50
adult (49) 49
hiv infections - drug therapy (46) 46
hiv (42) 42
virology (32) 32
immunology (31) 31
life sciences (30) 30
human immunodeficiency virus--hiv (28) 28
viral load (25) 25
hiv infections - virology (24) 24
aids (23) 23
anti-hiv agents - therapeutic use (23) 23
antiretroviral therapy (22) 22
microbiology (21) 21
hiv infection (19) 19
therapy (19) 19
cd4 lymphocyte count (18) 18
aids/hiv (17) 17
antiretroviral drugs (17) 17
hiv infections - complications (17) 17
pharmacology & pharmacy (17) 17
protease inhibitors (17) 17
treatment outcome (17) 17
risk factors (16) 16
acquired immune deficiency syndrome--aids (15) 15
active antiretroviral therapy (15) 15
drug therapy (15) 15
health aspects (15) 15
virus diseases (15) 15
santé publique et épidémiologie (14) 14
acquired immune deficiency syndrome (13) 13
aged (13) 13
antiretroviral therapy, highly active (13) 13
antiviral agents (13) 13
drug therapy, combination (13) 13
hiv infections - immunology (13) 13
human health and pathology (13) 13
human immunodeficiency virus (13) 13
cohort studies (12) 12
drug administration schedule (12) 12
hiv-1 - drug effects (12) 12
infection (12) 12
mortality (12) 12
patients (12) 12
prospective studies (12) 12
safety (12) 12
[sdv.spee]life sciences [q-bio]/santé publique et épidémiologie (11) 11
france - epidemiology (11) 11
hepatitis c (11) 11
hiv patients (11) 11
research article (11) 11
reverse transcriptase inhibitors - therapeutic use (11) 11
rna, viral - blood (11) 11
viruses (11) 11
[sdv.mhep.mi]life sciences [q-bio]/human health and pathology/infectious diseases (10) 10
cohort (10) 10
hepatitis (10) 10
hiv-1 (10) 10
hiv-1-infected patients (10) 10
human-immunodeficiency-virus (10) 10
infected patients (10) 10
multidisciplinary sciences (10) 10
population (10) 10
risk (10) 10
antiretroviral agents (9) 9
france (9) 9
hepatitis c virus (9) 9
hiv infections - epidemiology (9) 9
hiv-1 - isolation & purification (9) 9
hiv-infected patients (9) 9
infections (9) 9
medicine (9) 9
science (9) 9
analysis (8) 8
anti-hiv agents - administration & dosage (8) 8
care and treatment (8) 8
disease (8) 8
pharmacokinetics (8) 8
pharmacology (8) 8
cd4 antigen (7) 7
coinfection (7) 7
efficacy (7) 7
hiv-1 - genetics (7) 7
hiv-1 - physiology (7) 7
individuals (7) 7
plasma (7) 7
research (7) 7
tenofovir (7) 7
young adult (7) 7
antiretroviral therapy, highly active - methods (6) 6
biology and life sciences (6) 6
coinfection - drug therapy (6) 6
comorbidity (6) 6
drug resistance, viral (6) 6
epidemiology (6) 6
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


PLoS ONE, ISSN 1932-6203, 02/2017, Volume 12, Issue 2, p. e0170661
Journal Article
JAIDS Journal of Acquired Immune Deficiency Syndromes, ISSN 1525-4135, 02/2019, Volume 80, Issue 2, pp. 214 - 223
Journal Article
BMC Infectious Diseases, ISSN 1471-2334, 10/2010, Volume 10, Issue 1, pp. 303 - 303
Background: In France, it is estimated that 24% of HIV-infected patients are also infected with HCV. Longitudinal studies addressing clinical and public health... 
TRANSIENT ELASTOGRAPHY | DRUG-USERS | INFECTIOUS DISEASES | REAL-LIFE | CHRONIC HEPATITIS-C | ACTIVE ANTIRETROVIRAL THERAPY | LIVER FIBROSIS | ALPHA-2A PLUS RIBAVIRIN | HUMAN-IMMUNODEFICIENCY-VIRUS | CLINICAL PROGRESSION | MORTALITE 2005 | Carcinoma, Hepatocellular - epidemiology | Hepatitis C, Chronic - pathology | HIV Infections - epidemiology | Humans | Middle Aged | Male | RNA, Viral - blood | Hepatitis C, Chronic - complications | Viral Load | Liver Neoplasms - epidemiology | HIV Infections - pathology | HIV-1 - isolation & purification | Adult | Anti-HIV Agents - therapeutic use | Female | Surveys and Questionnaires | Hepatitis C, Chronic - epidemiology | Hepacivirus - isolation & purification | France - epidemiology | Risk Factors | CD4 Lymphocyte Count | Hepatitis C, Chronic - drug therapy | Disease Progression | Antiretroviral Therapy, Highly Active | Medication Adherence | HIV Infections - complications | HIV Infections - drug therapy | Longitudinal Studies | Cohort analysis | Usage | Demographic aspects | Comorbidity | Distribution | Reports | Hepatitis C | HIV infection | Antiretroviral drugs | Liver diseases | Disease | Physicians | Mortality | Hepatitis | Liver cancer | Hospitals | Human immunodeficiency virus--HIV | Data collection | Behavior | Clinical medicine | Liver cirrhosis | Life Sciences | Human health and pathology | Infectious diseases
Journal Article
PLoS ONE, ISSN 1932-6203, 09/2018, Volume 13, Issue 9, p. e0203895
Journal Article
PLOS ONE, ISSN 1932-6203, 04/2019, Volume 14, Issue 4, pp. e0216010 - e0216010
Introduction Limited "real life" data on raltegravir (RAL) use during pregnancy are available. Thus, we aimed at describing effectiveness and safety of... 
WOMEN | TRANSMISSION | THERAPY | HIV | PHARMACOKINETICS | SAFETY | MULTIDISCIPLINARY SCIENCES | EFAVIRENZ | INHIBITORS | RITONAVIR | DELIVERY | Complications and side effects | Pregnant women | Physiological aspects | Dosage and administration | Research | Drug therapy | Raltegravir
Journal Article
Journal Article
Journal Article
PLoS ONE, ISSN 1932-6203, 08/2017, Volume 12, Issue 8, p. e0183376
Journal Article
PLoS ONE, ISSN 1932-6203, 11/2015, Volume 10, Issue 11, p. e0142698
Journal Article